UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Oxysterols: An expanding family of structurally diversified bioactive steroids

The Journal of steroid biochemistry and molecular biology, 2019-11, Vol.194, p.105443-105443, Article 105443

2019

Volltextzugriff (PDF)

Emerging concepts on the role of exosomes in lipid metabolic diseases

Biochimie, 2014-01, Vol.96, p.67-74

2014

Volltextzugriff (PDF)

Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties

Current medicinal chemistry, 2015-01, Vol.22 (30), p.3533

2015

Volltextzugriff (PDF)

From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite

Biochimie, 2016-11, Vol.130, p.109-114

2016

Volltextzugriff (PDF)

5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells

Biochemical pharmacology, 2013-07, Vol.86 (1), p.175-189

2013

Volltextzugriff (PDF)

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands

Chemistry and physics of lipids, 2011-09, Vol.164 (6), p.432-437

2011

Volltextzugriff (PDF)

The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers

Biochemical pharmacology, 2018-07, Vol.153, p.75-81

2018

Volltextzugriff (PDF)

Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies

Biochimica et biophysica acta, 2014-01, Vol.1841 (1), p.108-120

2014

Volltextzugriff (PDF)

[ 18 F]Si‐RiboRGD: From Design and Synthesis to the Imaging of α v β 3 Integrins in Melanoma Tumors

ChemPlusChem (Weinheim, Germany), 2012-05, Vol.77 (5), p.345-349

2012

Volltextzugriff (PDF)

[18F]Si-RiboRGD: From Design and Synthesis to the Imaging of αvβ3 Integrins in Melanoma Tumors

ChemPlusChem (Weinheim, Germany), 2012-05, Vol.77 (5), p.345-349

2012

Volltextzugriff (PDF)

Exosomes as intercellular signalosomes and pharmacological effectors

Biochemical pharmacology, 2011-05, Vol.81 (10), p.1171-1182

2011

Volltextzugriff (PDF)

Cholesterol metabolism and cancer: the good, the bad and the ugly

Current opinion in pharmacology, 2012-12, Vol.12 (6), p.673-676

2012

Volltextzugriff (PDF)

Cholesterol epoxide hydrolase and cancer

Current opinion in pharmacology, 2012-12, Vol.12 (6), p.696-703

2012

Volltextzugriff (PDF)

Cholesterol-5,6-epoxides: Chemistry, biochemistry, metabolic fate and cancer

Biochimie, 2013-03, Vol.95 (3), p.622-631

2013

Volltextzugriff (PDF)

Oxysterols are potential physiological regulators of ageing

Ageing research reviews, 2022-05, Vol.77, p.101615-101615, Article 101615

2022

Volltextzugriff (PDF)

When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite

Biochemical Society transactions, 2016-04, Vol.44 (2), p.631

2016

Volltextzugriff (PDF)

Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death

Biochemical pharmacology, 2017-11, Vol.144, p.18-28

2017

Volltextzugriff (PDF)

Oxysterols and related sterols: Implications in pharmacology and pathophysiology

Biochemical pharmacology, 2013-07, Vol.86 (1), p.1-2

2013

Volltextzugriff (PDF)

The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells

Biochemical and biophysical research communications, 2014-04, Vol.446 (3), p.681-686

2014

Volltextzugriff (PDF)

Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate

The Journal of steroid biochemistry and molecular biology, 2023-11, Vol.234, p.106396-106396, Article 106396

2023

Volltextzugriff (PDF)

Is cholesterol a risk factor for breast cancer incidence and outcome?

The Journal of steroid biochemistry and molecular biology, 2023-09, Vol.232, p.106346-106346, Article 106346

2023

Volltextzugriff (PDF)

One step synthesis of 6-oxo-cholestan-3β,5α-diol

Biochemical and biophysical research communications, 2014-04, Vol.446 (3), p.782-785

2014

Volltextzugriff (PDF)

Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite

Biochimie, 2018-10, Vol.153, p.139-149

2018

Volltextzugriff (PDF)

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study

The Journal of steroid biochemistry and molecular biology, 2017-05, Vol.169, p.210-218

2017

Volltextzugriff (PDF)

Cholesterol metabolism and resistance to tamoxifen

Current opinion in pharmacology, 2012-12, Vol.12 (6), p.683-689

2012

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)
Buchkapitel
(1)

Sprache

Englisch
(44)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxysterols: An expanding family of structurally diversified bioactive steroids

Emerging concepts on the role of exosomes in lipid metabolic diseases

Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties

From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite

5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands

The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers

Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies

[ 18 F]Si‐RiboRGD: From Design and Synthesis to the Imaging of α v β 3 Integrins in Melanoma Tumors

[18F]Si-RiboRGD: From Design and Synthesis to the Imaging of αvβ3 Integrins in Melanoma Tumors

Exosomes as intercellular signalosomes and pharmacological effectors

Cholesterol metabolism and cancer: the good, the bad and the ugly

Cholesterol epoxide hydrolase and cancer

Cholesterol-5,6-epoxides: Chemistry, biochemistry, metabolic fate and cancer

Oxysterols are potential physiological regulators of ageing

When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite

Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death

Oxysterols and related sterols: Implications in pharmacology and pathophysiology

The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells

Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate

Is cholesterol a risk factor for breast cancer incidence and outcome?

One step synthesis of 6-oxo-cholestan-3β,5α-diol

Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study

Cholesterol metabolism and resistance to tamoxifen

Aktive Filter

Suchergebnisse filtern